Abstract
High blood pressure (BP) is a clearly established, but modifiable, risk factor for early disability and death. Although most of the adverse outcomes occur in adulthood, it has become clear that high blood pressure is a life course problem that can become evident in early life. While few would dispute the importance of taking effective steps to identify and manage this condition in middle-aged and older people, relatively little attention has been paid to the problem of high blood pressure in children and adolescents. Although long considered a disease of aging, its prevalence is increasing in children and adolescents. Unlike in adults, hypertension (HTN) is not a common cause of heart failure in children and adolescents, even though the presence of severe hypertension is a condition in which congestive heart failure can be present. Acute severe hypertension should be evaluated emergently, and treatment should be instituted without delay to reduce risks such as severe elevation of blood pressure in a child, which may lead to devastating complications. Several available drugs have been shown to be safe and effective in children with severe hypertension, although more research is needed to guide the management of these patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Lurbe E, Agabiti-Rosei E, Cruickshank JK, Dominiczak A, Erdine S, Hirth A, et al. 2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents. J Hypertens. 2016;34:1887–920. https://doi.org/10.1097/HJH.0000000000001039.
Flynn JT, Kaelber DC, Baker-Smith CM, Blowey D, Carroll AE, Daniels SR, SUBCOMMITTEE ON SCREENING AND MANAGEMENT OF HIGH BLOOD PRESSURE IN CHILDREN, et al. Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics. 2017;140:e20171904. https://doi.org/10.1542/peds.2017-1904.
Falkner B. Hypertension in children and adolescents: epidemiology and natural history. Pediatr Nephrol. 2010;25:1219–24. https://doi.org/10.1007/s00467-009-1200-3.
Song P, Zhang Y, Yu J, Zha M, Zhu Y, Rahimi K, Rudan I. Global prevalence of hypertension in children: a systematic review and meta-analysis. JAMA Pediatr. 2019;173:1154–63. https://doi.org/10.1001/jamapediatrics.2019.3310.
Flynn JT, Tullus K. Severe hypertension in children and adolescents: pathophysiology and treatment. Pediatr Nephrol. 2009;24:1101–12.
Seeman T, Hamdani G, Mitsnefes M. Hypertensive crisis in children and adolescents. Pediatr Nephrol. 2019;34:2523–37. https://doi.org/10.1007/s00467-018-4092-2.
Baracco R. A practical guide to the management of severe hypertension in children. Pediatr Drugs. 2020;22:13–20. https://doi.org/10.1007/s40272-019-00377-z.
Larkins N, Lurbe E, Flynn JT. Evaluation and management of hypertension in children. In: Emma F, Goldstein S, Bagga A, Bates CM, Shroff R, editors. Pediatric nephrology. Berlin, Heidelberg: Springer; 2021. https://doi.org/10.1007/978-3-642-27843-3_123-1.
Belsha C. Management of hypertensive emergencies. In: Pediatric hypertension. Portman Humana Press; 2013. p. 557–71. https://doi.org/10.1007/978-1-62703-490-6_37.
Tabbutt S, Nicolson SC, Adamson PC, Zhang X, Hofman ML, Wells W, et al. The safety, efficacy, and pharmacokinetics of esmolol for blood pressure control immediately after repair of coarctation of the aorta in infants and children: a multicenter, double-blind, randomized trial. J Thorac Cardiovasc Surg. 2008;136:321–8. https://doi.org/10.1016/j.jtcvs.2007.09.086.
Flynn JT, Bradford MC, Harvey EM. Intravenous hydralazine in hospitalized children and adolescents with hypertension. J Pediatr. 2016;168:88–92. https://doi.org/10.1016/j.jpeds.2015.07.070.
Thomas CA, Mofett BS, Wagner JL, Mott AR, Feig DI. Safety and efcacy of intravenous labetalol for hypertensive crisis in infants and small children. Pediatr Crit Care Med. 2011;12:28–32. https://doi.org/10.1097/PCC.0b013e3181e328d8.
Tenney F, Sakarcan A. Nicardipine is a safe and efective agent in pediatric hypertensive emergencies. Am J Kidney Dis. 2000;35:E20. https://doi.org/10.1016/s0272-6386(00)70285-x.
Flynn JT, Mottes TA, Brophy PD, Kershaw DB, Smoyer WE, Bunchman TE. Intravenous nicardipine for treatment of severe hypertension in children. J Pediatr. 2001;139:38–43. https://doi.org/10.1067/mpd.2001.114030.
Drover DR, Hammer GB, Barrett JS, Cohane CA, Reece T, Zajicek A, et al. Evaluation of sodium nitroprusside for controlled hypotension in children during surgery. Front Pharmacol. 2015;6:136. https://doi.org/10.3389/fphar.2015.00136.
Stein DR, Ferguson MA. Evaluation and treatment of hypertensive crises in children. Integr Blood Press Control. 2016;16:49–58. https://doi.org/10.2147/IBPC.S50640.
Miyashita Y, Peterson D, Rees JM, Flynn JT. Isradipine for treatment of acute hypertension in hospitalized children and adolescents. J Clin Hypertens. 2010;12:850–5. https://doi.org/10.1111/j.1751-7176.2010.00347.x.
Halling SE, Asling-Monemi K, Herthelius M, Celsi G, Vavilis G, Kuru NK, et al. Minoxidil therapy in children and young adult patients with renal disease and refractory hypertension: value when multidrug regimens have failed to achieve blood pressure control. J Hum Hypertens. 2010;24:552–4. https://doi.org/10.1038/jhh.2010.40.
Egger DW, Deming DD, Hamada N, Perkin RM, Sahney S. Evaluation of the safety of short-acting nifedipine in children with hypertension. Pediatr Nephrol. 2002;17:35–40. https://doi.org/10.1007/s004670200006.
Yiu V, Orrbine E, Rosychuk RJ, MacLaine P, Goodyer P, Girardin C, et al. The safety and use of short-acting nifedipine in hospitalized children. Pediatr Nephrol. 2004;19:644–50. https://doi.org/10.1007/s00467-004-1444-x.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Ethics declarations
None.
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Lurbe, E., Aguilar, F. (2023). Heart Failure in Severely Hypertensive Children. In: Dorobantu, M., Voicu, V., Grassi, G., Agabiti-Rosei, E., Mancia, G. (eds) Hypertension and Heart Failure. Updates in Hypertension and Cardiovascular Protection. Springer, Cham. https://doi.org/10.1007/978-3-031-39315-0_3
Download citation
DOI: https://doi.org/10.1007/978-3-031-39315-0_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-39314-3
Online ISBN: 978-3-031-39315-0
eBook Packages: MedicineMedicine (R0)